Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Clinical trial NCT05088356 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05088356
Sponsor: Stanford University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Cell Transplantation (HCT)Advanced Hematologic Malignancies Acute Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndromes Myeloproliferative Disorders

Start date: 2021-09-07
Primary completion: 2028-05-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.